News / Africa

Tough TB Responds to Drug Treatment

A young patient with potentially fatal MDR TB in isolation in a hospital in South Africa (Photo: D.Taylor)
A young patient with potentially fatal MDR TB in isolation in a hospital in South Africa (Photo: D.Taylor)

Multimedia

Audio
Joe DeCapua
An antibiotic used to treat severe infections shows promise against a very resistant and deadly form of tuberculosis. XDR-TB is resistant to at least four of the drugs used most often against the disease.


Extensively drug resistant tuberculosis – or XDR-TB – is still considered rare, although cases have been reported in nearly 80 countries. Health officials believe the number of XDR-TB cases is underreported because there’s no specific test for it.

It can be cured, but the odds against that happening are often quite high. It can kill quickly, especially if a person is co-infected with HIV, the virus that causes AIDS.

Dr. Ray Chen, a staff clinician at the National Institute of Allergy and Infectious Diseases, says XDR-TB is the next step after MDR-TB, or multi-drug resistant tuberculosis, which is a lot more common.

“That’s been a known problem for many years, primarily as a result of people who don’t take their drugs well. And then the tuberculosis bug slowly develops resistance to the drugs that are used,” he said.

MDR-TB is resistant to two of the top line drugs used for standard tuberculosis therapy. When the disease becomes resistant to two additional first-line drugs, it’s upgraded to XDR-TB.

“It came to world attention in 2006 in a study in South Africa where a number of patients were found to have this extensive resistance to tuberculosis drugs, and they had a very high mortality rate. And so it became recognized as a major problem for tuberculosis,” he said.

In fact, the mortality rate was as high at 90 percent in patients also infected with HIV.

Standard TB treatment can take up to six months. MDR-TB treatment can last between 18 and 24 months.

So researchers knew that more drugs were needed to tackle the various forms of TB.  They had heard of some informal studies using the drug linezolid on TB patients with some success. But there was no formal study.

Linezolid is a drug that’s already on the market and it’s approved for the use of resistant bacteria, which we call gram-positive bacteria that don’t respond to typical antibiotics.

To find out, researchers tested linezolid on 41 patients with XDR-TB. The patients already had been treated for six months with the best TB drugs available, but failed to respond. Chen said linezolid was added to their regimen.

“We found that adding the linezolid had a significant effect and that most of the patients converted their sputum from showing tuberculosis to not having tuberculosis in the sputum by six months. About 87 percent of the patients became negative for tuberculosis within six months. So it showed a very good response,” he said.

That’s the good news. The bad news is many of the patients suffered severe side effects. These include nerve problems with hands and feet going numb. There were also eye problems and abnormalities with red and white blood cells. Use of the drug was stopped before any of the patients suffered permanent damage.

As a result, Chen said more studies are needed to determine whether it can safely be used on a large-scale in combination with other drugs. He also says new, potent antibiotics will be coming on the market and these may be tested on TB, as well.

You May Like

Video Five Patients Given Experimental Ebola Drug Said To Be Improving

Experimental drugs have been tried on six people: three Westerners and now, three African pyhysicians More

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As Ukrainian military reclaims control of eastern cities residents rebuild their lives, but many say everyone is being treated with suspicion More

Video In Rural Kenya, Pressure Builds Against Female Circumcision

Girls learn to object; FGM practitioners face penalties from jail sentences to stiff fines More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Five Patients Given Experimental Ebola Drug Said to Be Improvingi
X
Carol Pearson
August 19, 2014 11:43 PM
The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.
Video

Video For Obama, Racial Violence is Personal Issue

The racial violence in the St. Louis suburb of Ferguson is presenting U.S. President Barack Obama with an issue to which he has a deep personal connection. To many Americans, Obama's election as America's first black president marked a turning point in race relations in the United States, and Obama has made ending the violence a policy priority. On Monday he issued a new call for calm and understanding. Luis Ramirez reports from the White House.
Video

Video Clinton-Obama Relationship Could Impact 2016 Election

President Barack Obama and former Secretary of State Hillary Clinton have a long and complicated relationship. That relationship took another turn recently when Clinton criticized the president’s foreign policy. VOA National Correspondent Jim Malone reports there is renewed attention on the Clinton-Obama relationship as Hillary Clinton considers running for
Video

Video Iran Looks to Maintain Influence in Baghdad With New Shia PM

Washington and Tehran share the goal of stopping Syrian-based militants in Iraq. But experts say it's Iran, not the United States, that will most influence how the new government in Baghdad approaches internal reforms and the war in Syria. VOA State Department Correspondent Scott Stearns has the story.

AppleAndroid